Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer

BACKGROUND: Poly (ADP-ribose) polymerase inhibitors targeting BRCA1/2 mutations are available for treating patients with high-grade serous ovarian cancer. These treatments may be more appropriately directed to patients who might respond if the tumor tissue is additionally tested by next-generation s...

Descripción completa

Detalles Bibliográficos
Autores principales: Eoh, Kyung Jin, Kim, Hye Min, Lee, Jung-Yun, Kim, Sunghoon, Kim, Sang Wun, Kim, Young Tae, Nam, Eun Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069205/
https://www.ncbi.nlm.nih.gov/pubmed/32164585
http://dx.doi.org/10.1186/s12885-020-6693-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069205/
https://www.ncbi.nlm.nih.gov/pubmed/32164585
http://dx.doi.org/10.1186/s12885-020-6693-y

Ejemplares similares